Skip to content
naulon
Not checkedNot checked for notices yet.

Synthesis of Lapachol and 4-Hydroxyquinazoline Derivatives as Candidates for Antimalarial Activity

Felipe Revoredo Benatti, Keoma Keyson Lima Cavalcante, Alexandre Orsato and 1 more

Orbital: The Electronic Journal of Chemistry · 2020

doi:10.17807/orbital.v12i4.1541 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

<p>Malaria is a disease that still plagues many tropical countries, affecting around 228 million people and with approximately 430 thousand deaths worldwide. The resistance of the causative protozoan against the existing antimalarials has been increasing, including for combination therapies based on artemisinin, a first-line treatment against malaria. Therefore, the search for new antimalarial agents becomes essential. Lapachol and febrifugine are substances with antimalarial activity with the potential for the development of new antimalarials, but with relevant cytotoxicity. In this work, we propose the synthesis of two derivatives, one from lapachol and the other from febrifugine, aiming at an improvement in antimalarial activity and a decrease in cytotoxicity. Lapachol was isolated from the sawdust of purple ipe and derivatized in a twostep synthesis, providing an unprecedented derivative in 25% yield overall. The febrifugine derivative was synthesized from 4-hydroxyquinazoline in 61% yield (2 steps). Both were purified by column chromatography and characterized by <sup>1</sup>H, <sup>13</sup>C NMR, HSQC and HMBC. Also, the parameters as clogP, the presence of atoms capable of acting as acceptors or donors of hydrogen bonds, molecular mass, topological surface area, rotatable bonds were determined in order to predict the solubility and bioavailability of this compounds as drug candidates.</p><p> </p><p>DOI: <a href="http://dx.doi.org/10.17807/orbital.v12i4.1541">http://dx.doi.org/10.17807/orbital.v12i4.1541</a></p><p> </p>

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.